C9
-
Official Full Name
complement component 9
-
Overview
This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009] -
Synonyms
C9; complement component 9; C9D; ARMD15; complement component C9;
- Recombinant Proteins
- Cell & Tissue Lysates
- Native Proteins
- Protein Pre-coupled Magnetic Beads
- Bos taurus (Bovine)
- Equus caballus (Horse)
- Human
- Mouse
- Mus musculus (Mouse)
- Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri)
- Oryctolagus cuniculus (Rabbit)
- Rabbit
- Rat
- Rattus norvegicus (Rat)
- Zebrafish
- E.coli
- E.coli expression system
- HEK293
- Human Plasma
- In Vitro Cell Free System
- Mammalian Cell
- Wheat Germ
- GST
- His
- Fc
- Avi
- T7
- N
- C
- Myc
- Non
Species | Cat.# | Product name | Source (Host) | Tag | Protein Length | Price |
---|---|---|---|---|---|---|
Human | C9-26247TH | Recombinant Human C9, GST-tagged | Wheat Germ | His | ||
Human | C9-5126H | Recombinant Human C9, His-tagged | E.coli | His | ||
Human | C9-7945HCL | Recombinant Human C9 293 Cell Lysate | HEK293 | Non | ||
Human | C9-58H | Native Human Complement C9 | Human Plasma | Non | ||
Human | C9-44HF | Recombinant Full Length Human C9 Protein, GST-tagged | In Vitro Cell Free System | GST | ||
Human | C9-0274H | Recombinant Human C9 Protein (Gln22-His265), N-His-tagged | E.coli | His | Gln22-His265 | |
Human | C9-5142H | Recombinant Human C9 protein, His-GST-tagged | E.coli | N-His-GST | 74-155aa | |
Human | C9-6214H | Recombinant Human C9 protein, His&Myc-tagged | E.coli | N-His&C-Myc | 22-265aa | |
Mouse | C9-2593M | Recombinant Mouse C9 Protein | Mammalian Cell | His | ||
Mouse | C9-1844M | Recombinant Mouse C9 protein, His-tagged | E.coli | His | Pro136~Arg512 | |
Mouse | C9-05M | Recombinant Mouse C9 Protein | E.coli | |||
Mouse | C9-1149M | Recombinant Mouse C9 Protein, His (Fc)-Avi-tagged | HEK293 | His&Fc&Avi | ||
Mouse | C9-1149M-B | Recombinant Mouse C9 Protein Pre-coupled Magnetic Beads | HEK293 | |||
Rat | C9-1056R | Recombinant Rat C9 Protein | Mammalian Cell | His | ||
Rat | C9-714R | Recombinant Rat C9 Protein, His (Fc)-Avi-tagged | HEK293 | His&Fc&Avi | ||
Rat | C9-714R-B | Recombinant Rat C9 Protein Pre-coupled Magnetic Beads | HEK293 | |||
Rat | C9-349R | Recombinant Rat C9 Protein, His-tagged | E.coli | His | Leu336-Arg554 | |
Rat | C9-04R | Recombinant Rat C9 Protein | E.coli | |||
Rabbit | C9-1845R | Recombinant Rabbit C9 protein, His & T7-tagged | E.coli | His&T7 | Pro139~Lys519 | |
Bos taurus (Bovine) | RFL3920BF | Recombinant Full Length Bovine Complement Component C9(C9) Protein, His-Tagged | E.coli expression system | His | Full Length of Mature Protein (22-548) | |
Equus caballus (Horse) | RFL28089EF | Recombinant Full Length Horse Complement Component C9(C9) Protein, His-Tagged | E.coli expression system | His | Full Length of Mature Protein (22-547) | |
Mus musculus (Mouse) | RFL27477MF | Recombinant Full Length Mouse Complement Component C9(C9) Protein, His-Tagged | E.coli expression system | His | Full Length (21-548) | |
Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) | RFL24106OF | Recombinant Full Length Oncorhynchus Mykiss Complement Component C9(C9) Protein, His-Tagged | E.coli expression system | His | Full Length (1-574) | |
Oryctolagus cuniculus (Rabbit) | RFL34979OF | Recombinant Full Length Rabbit Complement Component C9(C9) Protein, His-Tagged | E.coli expression system | His | Full Length of Mature Protein (22-557) | |
Rattus norvegicus (Rat) | RFL12988RF | Recombinant Full Length Rat Complement Component C9(C9) Protein, His-Tagged | E.coli expression system | His | Full Length (21-554) | |
Zebrafish | C9-3035Z | Recombinant Zebrafish C9 | Mammalian Cell | His |
- Background
- Quality Guarantee
- Case Study
- Involved Pathway
- Protein Function
- Interacting Protein
- Other Resource
What is C9 protein?
C9 (complement C9) gene is a protein coding gene which situated on the short arm of chromosome 5 at locus 5p13. C9 is A multidomain protein containing the N-terminal type 1 thromboplaque protein (TSP) domain, LDL-receptor class A repeats, and multiple potential transmembrane regions. C9) is a key component of the human complement system, which plays a crucial role in the formation of the Membrane Attack Complex (MAC), which forms pores by combining with other components of the MAC. This allows MAC to effectively penetrate and destroy the cell membrane of the target cell. During complement activation, multiple copies of the C9 molecule are inserted into the MAC, forming a polyC9 structure that is key to the perforation activity of the MAC. The C9 protein is consisted of 559 amino acids and its molecular mass is approximately 63.2 kDa.
What is the function of C9 protein?
C9 is the final component of the complement system's membrane attack complex, which combines with other components of the MAC to complete the formation of pores, resulting in the cleavage of bacteria or target cells. The assembly of MAC on the bacterial membrane forms a hole, thereby destroying the bacterial membrane tissue, which is the primary biological function of C9.
C9 plays a vital immune defense role against invading microorganisms, such as bacteria and viruses, by participating in the formation of MAC. C9 and its related complement activation pathways play an important role in the regulation of immune response, including enhancing antibody response, clearing immune complexes and apoptotic cells.
C9 Related Signaling Pathway
C9 protein is mainly involved in three signaling pathways in the complement system: classical complement pathway, replacement complement pathway and lectin pathway. Specifically, the classical complement pathway is an antibody-mediated process of complement activation in which C9, as the last component of the membrane attack complex (MAC), binds to the C5b-8 complex to form a channel capable of penetrating the cell membrane, resulting in the cleavage of the target cell.
Alternative complement pathway: Also known as the bypass pathway, it does not rely on antibodies, but directly activates C3 through complement proteins such as B factors, D factors, and readiness hormone (P-factor), which in turn triggers a cascade of reactions. C9 plays the same role in this pathway as the classical pathway, participating in the formation of MAC and carrying out the cell lysis function.
The lectin pathway directly recognizes the sugar structure on the surface of pathogens through pattern recognition molecules such as mannose-binding lectin (MBL), thereby activating the complement system. C9's role in this pathway is also as part of the MAC, involved in the elimination of foreign pathogens.
C9 Related Diseases
Diseases associated with the C9 protein include inherited complement deficiency disorders and autoimmune disorders. Hereditary complement deficiency diseases are caused by the abnormal function of the C9 protein due to mutations in the C9 gene. The most common hereditary complement deficiency disorder is hereditary glomerulonephritis, which is characterized by recurrent episodes of hematuria and proteinuria that can eventually lead to kidney failure. Other hereditary complement deficiency diseases include hereditary angioedema and hereditary IgA nephropathy.
Autoimmune diseases are diseases in which the immune system attacks its own tissues. In some autoimmune diseases, C9 protein may be involved in pathological processes. For example, in rheumatoid arthritis, the C9 protein may be involved in the formation and deposition of immune complexes that lead to arthritis symptoms. In addition, other autoimmune diseases such as systemic lupus erythematosus may also be associated with abnormal function of the C9 protein.
Bioapplications of C9
C9 protein is used as a laboratory reagent for the detection of complement activity and the functional study of complement system. In clinical diagnosis, the detection of C9 protein can help diagnose certain complement-related diseases, such as hereditary complement deficiency. The activity and expression level of C9 protein can be used as an indicator to evaluate the effectiveness of therapeutic strategies, especially in the treatment of diseases related to the complement system.
High Purity
Fig1. SDS-PAGE (C9-0274H)
.
Fig2. SDS-PAGE (C9-1844M)
Case Study 1: Mariann Kremlitzka, 2018
Age-related macular degeneration (AMD) is a progressive disease of the central retina and the leading cause of irreversible vision loss in the western world. The involvement of abnormal complement activation in AMD has been suggested by association of variants in genes encoding complement proteins with disease development. A low-frequency variant (p.P167S) in the complement component C9 (C9) gene was recently shown to be highly associated with AMD; however, its functional outcome remains largely unexplored. This study revealed five novel rare genetic variants (p.M45L, p.F62S, p.G126R, p.T170I and p.A529T) in C9 in AMD patients, and evaluate their functional effects in vitro together with the previously identified (p.R118W and p.P167S) C9 variants. The results demonstrate that the concentration of C9 is significantly elevated in patients' sera carrying the p.M45L, p.F62S, p.P167S and p.A529T variants compared with non-carrier controls. Comparing the polymerization of the C9 variants, the p.P167S mutant spontaneously aggregates, while the other mutant proteins (except for C9 p.A529T) fail to polymerize in the presence of zinc.
Fig1. Measurement of serum C9 levels in C9 carriers.
Fig2. Concentration of C9 in the secreted supernatants was measured by ELISA.
Case Study 2: Hangeun Kim, 2013
Hepatitis C virus (HCV) proteins inhibit complement component expression, which may attenuate immunity against infection. This study examined whether HCV regulates the membrane attack complex (MAC) via complement component C9. MAC is composed of C5b to C9 (C5b-9) and mediates cell lysis of invaded pathogens. Liver biopsy specimens from chronically HCV-infected patients exhibited a lower level of C9 mRNA expression than liver biopsy specimens from unrelated disease or healthy control human liver RNA. Hepatocytes infected with cell culture-grown HCV or expressing HCV core protein also displayed significant repression of C9 mRNA and protein levels. Promoter analysis suggested that the T cell factor-4 (TCF-4E) transcription factor is responsible for HCV core-mediated C9 promoter regulation. Sera from chronically HCV-infected patients displayed a lower level of C5b-9 and a reduced antimicrobial effect on model organisms compared to unrelated patient sera or sera from healthy volunteers.
Fig3. The repression of C9 protein was examined with HCV genotype 2a-infected or uninfected hepatocyte lysates by Western blotting.
Fig4. IFN-γ-mediated dose-dependent stimulation of C9 promoter activity is shown after 18 h of treatment.
C9 involved in several pathways and played different roles in them. We selected most pathways C9 participated on our site, such as Complement and coagulation cascades, Prion diseases, Amoebiasis, which may be useful for your reference. Also, other proteins which involved in the same pathway with C9 were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|---|
Complement and coagulation cascades | C4BPB;F9;GM5077;C8G;C3;F7;MBL2;LOC100514666;PLAU |
Prion diseases | NCAM1;C5;C1QC;FYN;MAP2K2;PRKACB;C1QB;NOTCH1;LAMC1 |
Amoebiasis | CD14;RAB7B;SERPINB4;RAB7;IL1B2;PIK3CD;CTSG;RAB5C;LAMA4 |
Systemic lupus erythematosus | C2;HIST1H2BP;HIST1H4I;GM14478;C3;H2AFY2;HIST1H2AG;C6;H2AFJ |
C9 has several biochemical functions, for example, . Some of the functions are cooperated with other proteins, some of the functions could acted by C9 itself. We selected most functions C9 had, and list some proteins which have the same functions with C9. You can find most of the proteins on our site.
Function | Related Protein |
---|
C9 has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with C9 here. Most of them are supplied by our site. Hope this information will be useful for your research of C9.
d-mannose
Research Area
Related articles
- Reviews
- Q&As
Customer Reviews (3)
Write a reviewAccurate protein structural analysis, indispensable for our investigations.
Exceptional protein expression optimization support, highly appreciated.
Reliable mass spectrometry analysis, pivotal for advancing proteomics research.
Q&As (7)
Ask a questionC9 mediates inflammation and is key in defense against bacterial infections.
C9 is crucial in forming the MAC, which lyses pathogens and damaged cells in immune defense.
C9 interacts with other complement components to propagate the complement cascade and immune response.
Variations in C9 function or expression can disrupt immune regulation, affecting disease susceptibility and severity.
C9 deficiency increases vulnerability to recurrent bacterial infections due to weakened immune response.
C9 influences ischemic injury outcomes by mediating inflammatory and immune responses.
In autoimmune diseases, C9 can exacerbate symptoms by overactivating the complement system.
Ask a Question for All C9 Products
Required fields are marked with *
My Review for All C9 Products
Required fields are marked with *